CAS 210891-04-6 BMS-207940 - Analytical Products / Alfa Chemistry

CAT	AP210891046
CAS	210891-04-6
Structure
MDL Number	MFCD05260689
Molecular Weight	536.64
InChI Key	ORJRYNKVKJAJPY-UHFFFAOYSA-N

Description	≥98% (HPLC)
Solubility	DMSO: 20 mg/mL, clear
Assay	≥98% (HPLC)
Color	white to beige
Form	powder
Size	5MG, 25MG
Storage Conditions	room temp

1

11 C-BMS-5p and 18 F-FBzBMS: radiolabeled analogs of BMS-207940, a potent and selective antagonist of endothelin receptor subtype A

Arvind Chopra

PMID: 23833790

1

Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a Highly Potent and Orally Active ET(A) Selective Antagonist

Natesan Murugesan, Zhengxiang Gu, Steven Spergel, Marian Young, Ping Chen, Arvind Mathur, Leslie Leith, Mark Hermsmeier, Eddie C-K Liu, Rongan Zhang, Eileen Bird, Tom Waldron, Anthony Marino, Barry Koplowitz, etc.

J Med Chem. 2003 Jan 2;46(1):125-37.

PMID: 12502366

1

BMS-193884 and BMS-207940 Bristol-Myers Squibb

Martin Hulpke-Wette, Reiner Buchhorn

Curr Opin Investig Drugs. 2002 Jul;3(7):1057-61.

PMID: 12186267

1

Simulation of the Impact of Atropisomer Interconversion on Plasma Exposure of Atropisomers of an Endothelin Receptor Antagonist

Y S Zhou, L K Tay, D Hughes, S Donahue

J Clin Pharmacol. 2004 Jul;44(7):680-8.

PMID: 15199072

1

Synthesis and in Vivo Evaluation of Novel PET Radioligands for Imaging the endothelin-A Receptor

William B Mathews, Natesan Murugesan, Jinsong Xia, Ursula Scheffel, John Hilton, Hayden T Ravert, Robert F Dannals, Zsolt Szabo

J Nucl Med. 2008 Sep;49(9):1529-36.

PMID: 18703610

* Products or Services Interested: BMS-207940 (210891-04-6)
* Your question
* Name
* Email
Verification Code